Teva Pharmaceutical Indus (TEVA)
17.16
+0.01 +0.06%
NYSE
Sep 22, 09:31
Delayed 2m
USD
View All Key Stats
TEVA Key Stats
| Income Statement | |
| Revenue (TTM) | 23.37B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -6.13 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -5.886B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 49.61% |
| Profit Margin (Quarterly) | -105.0% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 6.44% |
| Price and Valuation | |
| Market Cap | 17.43B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 0.7408 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 0.7153 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 1.252 |
| Free Cash Flow (Quarterly) | 548.00M |
| Return on Equity (TTM) | -20.65% |
View All TEVA News
TEVA News
-
WireHeadlineTime (ET)
-
Yahoo09/22 07:51
-
Yahoo09/21 16:18
-
Yahoo09/21 13:44
-
Yahoo09/21 13:30
-
PR Newswire09/21 11:20
-
MT Newswires09/21 10:51
-
PR Newswire09/21 09:00
-
Yahoo09/21 07:37
-
Yahoo09/20 19:30
-
PR Newswire09/20 17:31
View All Events
TEVA Events
| Date | Type | Description |
|---|---|---|
| 11/02/2017 08:00 EDT | Misc | Teva Pharmaceutical Industries Ltd Third Quarter Earnings Conference Call in 2017 |
| 11/02/2017 | Earnings | Teva Pharmaceutical Industries Ltd Third Quarter Earnings in 2017 Release |
| 08/25/2017 | Dividends | Amount: 0.085, Declared Date: Aug 02 2017, Pay Date: Sep 14 2017 |
| 08/03/2017 07:30 EDT | Misc | Teva Pharmaceutical Industries Ltd Second Quarter Earnings Conference Call in 2017 |
| 08/03/2017 | Earnings | Teva Pharmaceutical Industries Ltd Second Quarter Earnings in 2017 Release |
| 06/01/2017 | Dividends | Amount: 0.34, Declared Date: May 12 2017, Pay Date: Jun 22 2017 |
| 05/11/2017 08:00 EDT | Misc | Teva Pharmaceutical Industries Ltd First Quarter Earnings Conference Call in 2017 |
| 05/11/2017 | Earnings | Teva Pharmaceutical Industries Ltd First Quarter Earnings in 2017 Release |
| 02/28/2017 | Dividends | Amount: 0.34, Declared Date: Feb 13 2017, Pay Date: Mar 20 2017 |
| 02/15/2017 | Misc | Teva Pharmaceutical Industries Ltd Annual Report in 2016 |
TEVA Fundamentals
Income Statement View Statement
TEVA Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
TEVA One Page Reports
- One Page Report Download
TEVA Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Target Price | |
| Price | 17.16 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.tevapharm.com
- Investor Relations URL: http://ir.tevapharm.com/phoenix.zhtml?c=73925&p=irol-irhome
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Next Earnings Release: Nov. 02, 2017
- Last Earnings Release: Aug. 03, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Aug. 25, 2017
- Description: Teva Pharmaceutical Industries Ltd is a pharmaceutical company which develops, produces and markets generic and specialty medicines which include chemical and therapeutic medicines in a variety of dosage forms and central nervous system medicines.
TEVA Comparables
EditTEVA Excel Add-In Codes
- Name: =YCI("TEVA","name")
- Description: =YCI("TEVA","description")
- Sector: =YCI("TEVA","sector")
- Industry: =YCI("TEVA","industry")
- Est. Current Fiscal Year End: =YCI("TEVA","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other TEVA Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- TEVA Tweets Stocktwits
Advertisement
